The effect of Prednisolone vs Dexamethasone on Covid-19 in Pregnancy: an open labelled randomised control trial

Phase 3

• Conditions: covid-19; pregnancy; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy; Infection - Other infectious diseases; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12621001603808
• Lead Sponsor: Monash Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-24
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 192

Inclusion Criteria

Pregnant women >16 weeks with COVID-19, hospitalised with an oxygen requirement.
Comorbidities are included, not limited to obesity, hypertension, diabetes, pre-existing illnesses are included.

Exclusion Criteria

Pregnancy <16 weeks’ gestation
Not requiring oxygen
Contraindications to receiving corticosteroids

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
WHO ordinal scale of clinical improvement compared at day 5 and at day 10.[day 5 and 10 of admission to hospital.<br>This is a comparative study. <br>Both of these are the primary timepoints]